chr16-87381644-T-C

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_024735.5(FBXO31):​c.340+1761A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.432 in 152,158 control chromosomes in the GnomAD database, including 17,209 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.43 ( 17209 hom., cov: 33)

Consequence

FBXO31
NM_024735.5 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.0150

Publications

20 publications found
Variant links:
Genes affected
FBXO31 (HGNC:16510): (F-box protein 31) This gene is a member of the F-box family. Members are classified into three classes according to the substrate interaction domain, FBW for WD40 repeats, FBL for leucing-rich repeats, and FBXO for other domains. This protein, classified into the last category because of the lack of a recognizable substrate binding domain, has been proposed to be a component of the SCF ubiquitination complex. It is thought to bind and recruit substrate for ubiquitination and degradation. This protein may have a role in regulating the cell cycle as well as dendrite growth and neuronal migration. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2013]
FBXO31 Gene-Disease associations (from GenCC):
  • autosomal recessive non-syndromic intellectual disability
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • cerebral palsy
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • intellectual disability, autosomal recessive
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
  • intellectual disability, autosomal recessive 45
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 16-87381644-T-C is Benign according to our data. Variant chr16-87381644-T-C is described in ClinVar as Benign. ClinVar VariationId is 1239788.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.976 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_024735.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FBXO31
NM_024735.5
MANE Select
c.340+1761A>G
intron
N/ANP_079011.3
FBXO31
NM_001282683.2
c.-177+8093A>G
intron
N/ANP_001269612.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FBXO31
ENST00000311635.12
TSL:1 MANE Select
c.340+1761A>G
intron
N/AENSP00000310841.4
FBXO31
ENST00000636077.2
TSL:5
c.340+1761A>G
intron
N/AENSP00000490402.2
FBXO31
ENST00000618298.6
TSL:5
c.-177+8093A>G
intron
N/AENSP00000479703.1

Frequencies

GnomAD3 genomes
AF:
0.432
AC:
65745
AN:
152040
Hom.:
17188
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.194
Gnomad AMI
AF:
0.519
Gnomad AMR
AF:
0.609
Gnomad ASJ
AF:
0.608
Gnomad EAS
AF:
0.998
Gnomad SAS
AF:
0.862
Gnomad FIN
AF:
0.555
Gnomad MID
AF:
0.604
Gnomad NFE
AF:
0.433
Gnomad OTH
AF:
0.474
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.432
AC:
65789
AN:
152158
Hom.:
17209
Cov.:
33
AF XY:
0.456
AC XY:
33955
AN XY:
74384
show subpopulations
African (AFR)
AF:
0.194
AC:
8055
AN:
41520
American (AMR)
AF:
0.609
AC:
9313
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.608
AC:
2111
AN:
3472
East Asian (EAS)
AF:
0.998
AC:
5173
AN:
5182
South Asian (SAS)
AF:
0.862
AC:
4160
AN:
4828
European-Finnish (FIN)
AF:
0.555
AC:
5874
AN:
10580
Middle Eastern (MID)
AF:
0.616
AC:
181
AN:
294
European-Non Finnish (NFE)
AF:
0.433
AC:
29437
AN:
67980
Other (OTH)
AF:
0.480
AC:
1012
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1639
3278
4916
6555
8194
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
612
1224
1836
2448
3060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.432
Hom.:
31204
Bravo
AF:
0.426
Asia WGS
AF:
0.871
AC:
3023
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Feb 24, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 29044928)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
2.4
DANN
Benign
0.69
PhyloP100
0.015
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs933717; hg19: chr16-87415250; API